Cary Street Partners Investment Advisory’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $394K | Buy |
3,552
+433
| +14% | +$48K | 0.19% | 127 |
|
|
2025
Q1 | $349K | Buy |
3,119
+346
| +12% | +$38.8K | 0.2% | 131 |
|
|
2024
Q4 | $256K | Sell |
2,773
-4,196
| -60% | -$388K | 0.17% | 138 |
|
|
2024
Q3 | $584K | Sell |
6,969
-10
| -0.1% | -$838 | 0.02% | 464 |
|
|
2024
Q2 | $479K | Buy |
6,979
+650
| +10% | +$44.6K | 0.02% | 483 |
|
|
2024
Q1 | $464K | Buy |
6,329
+16
| +0.3% | +$1.17K | 0.02% | 469 |
|
|
2023
Q4 | $511K | Buy |
6,313
+2,024
| +47% | +$164K | 0.02% | 422 |
|
|
2023
Q3 | $321K | Buy |
4,289
+1,842
| +75% | +$138K | 0.02% | 466 |
|
|
2023
Q2 | $189K | Buy |
2,447
+50
| +2% | +$3.85K | 0.01% | 525 |
|
|
2023
Q1 | $199K | Sell |
2,397
-75
| -3% | -$6.22K | 0.01% | 472 |
|
|
2022
Q4 | $212K | Sell |
2,472
-347
| -12% | -$29.8K | 0.02% | 461 |
|
|
2022
Q3 | $174K | Buy |
2,819
+117
| +4% | +$7.22K | 0.01% | 463 |
|
|
2022
Q2 | $167K | Buy |
+2,702
| New | +$167K | 0.01% | 446 |
|
|
2021
Q1 | – | Sell |
-4,685
| Closed | -$273K | – | 358 |
|
|
2020
Q4 | $273K | Buy |
4,685
+2,617
| +127% | +$152K | 0.05% | 267 |
|
|
2020
Q3 | $131K | Buy |
+2,068
| New | +$131K | 0.03% | 328 |
|